Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
9,312
-187
-2% -$21.9K 0.07% 133
2026
Q1
$1.14M Buy
9,499
+1,242
+15% +$143K 0.08% 118
2025
Q4
$869K Buy
8,257
+667
+9% +$62.6K 0.06% 148
2025
Q3
$637K Buy
7,590
+16
+0.2% +$1.32K 0.05% 132
2025
Q2
$600K Sell
7,574
-236
-3% -$18.8K 0.06% 134
2025
Q1
$701K Sell
7,810
-1,317
-14% -$123K 0.07% 109
2024
Q4
$908K Sell
9,127
-1,688
-16% -$174K 0.09% 98
2024
Q3
$1.23M Buy
10,815
+290
+3% +$34.5K 0.12% 97
2024
Q2
$1.3M Buy
10,525
+289
+3% +$37.2K 0.14% 86
2024
Q1
$1.35M Buy
10,236
+1,048
+11% +$129K 0.16% 80
2023
Q4
$1M Sell
9,188
-409
-4% -$42.5K 0.13% 92
2023
Q3
$988K Buy
9,597
+837
+10% +$90.2K 0.15% 82
2023
Q2
$1.01M Buy
8,760
+1,248
+17% +$142K 0.16% 80
2023
Q1
$799K Buy
7,512
+644
+9% +$69.5K 0.14% 97
2022
Q4
$762K Buy
6,868
+1,701
+33% +$174K 0.14% 96
2022
Q3
$445K Buy
5,167
+590
+13% +$52.7K 0.09% 137
2022
Q2
$417K Buy
4,577
+245
+6% +$21.7K 0.09% 135
2022
Q1
$355K Sell
4,332
-3,508
-45% -$277K 0.07% 190
2021
Q4
$601K Buy
+7,840
New +$624K 0.13% 132

Other funds holding MRK

Quent Capital's MRK Position: Q2 2026 in Review

Quent Capital reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $21.9K and leaving 9,312 shares worth $1.2M. The position accounts for 0.07% of the portfolio, ranked #133.

Quent Capital first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.35M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Quent Capital held 9,312 shares of Merck worth $1.2M as of Q2 2026.
  • Quent Capital sold 187 Merck shares in Q2 2026, an estimated $21.9K.
  • Merck made up 0.07% of Quent Capital's portfolio in Q2 2026, its #133 holding.
  • Quent Capital first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Quent Capital's Merck position peaked at $1.35M in Q1 2024.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.